Coverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 28, 2026. Only the current version of each report is used.
43,653 report citations, newest first.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…t; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: Nation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
…Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authoriza…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 2587· this member:Sponsored
…ated Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Huma…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…ar 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 3345· this member:Cosponsored
…ional Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supp…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 4189· this member:Cosponsored
…Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: O…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 5244· this member:Cosponsored
…ncy and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and Aff…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Education
$90,115
Spent on own lobbying
CitesS. 1296· this member:Cosponsored
…10617, the VET CARE Act of 2026; All provisions. - General issues related to federal research related to Quantum education and workforce training. - H.R.1048/ S.1296, the DETERRENT Act; All provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Education
$90,115
Spent on own lobbying
CitesS. 2511· this member:Cosponsored
…4.016A); International Research and Studies (84.017A); Centers for International Business Education (84.220A); Language Resource Centers (84.229A). - H.R. 4806/S. 2511 "The College Transparency Act"; All provisions. - H.R. 9896, the Workforce Innovation for Next-Gen Growth in Skies (WINGS) Act of 2026; All provisions. - H.R.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Sports/Athletics
$90,115
Spent on own lobbying
CitesS. 4668· this member:CosponsoredRecorded votes on 11 roll calls
- General issues related to Name, Image, Likeness in collegiate athletics. - S. 4668, the Protect College Sports Act; All provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENTER FOR AI SAFETY ACTION FUND, INC. · lobbying firm or registrant: CENTER FOR AI SAFETY ACTION FUND, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Oct 20, 2026 · issue area: Defense
$60,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to artificial intelligence policy
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CNX RESOURCES CORPORATION · lobbying firm or registrant: CNX RESOURCES CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$120,000
Spent on own lobbying
CitesS. 2304· this member:Cosponsored
Natural gas industry energy policy Methane abatement and capture policy H.R. 1881 / S.2304 - Methane Reduction and Economic Growth Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CNX RESOURCES CORPORATION · lobbying firm or registrant: CNX RESOURCES CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$120,000
Spent on own lobbying
CitesS. 2304· this member:Cosponsored
Natural gas industry tax policy H.R. 1881 / S.2304 - Methane Reduction and Economic Growth Act 26 U.S.C. Section 45Z tax policy 26 U.S.C. Section 45V
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHUBB INA HOLDINGS INC. · lobbying firm or registrant: CHUBB INA HOLDINGS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Insurance
$410,000
Spent on own lobbying
CitesS. 4395· this member:Cosponsored
Various issues related to the Federal Insurance Office (FIO). Issues related to the extension of the Terrorism Risk Insurance Program. S. 4395 - Terrorism Risk Insurance Program Reauthorization Act of 2026 H.R. 7128 - TRIA Program Reauthorization Act of 2026 Issues related to international capital sta…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUNTORY GLOBAL SPIRITS (FORMERLY BEAM SUNTORY INC.) · lobbying firm or registrant: THE WASHINGTON TAX & PUBLIC POLICY GROUP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Agriculture
$30,000
Paid to lobbying firm
CitesH.R. 6500· this member:Recorded votes on 4 roll calls
Issues related to S.Amdt. 6747 to H.R. 6500 - Continuing Appropriations and Extensions Act, 2027 (P.L. 119-103)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Clean Air and Water (quality)
$700,000
Spent on own lobbying
CitesS. 5653· this member:Sponsored
…ments to Protect National Security Act of 2025, All Titles H.R. 6398, Reducing and Eliminating Duplicative Environmental Regulations (RED Tape) Act, All Titles S. 5653, Bipartisan American Affordability and Jobs Act of 2026, Sections 1201-1205
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$700,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
Defense Minerals and Energy Supply Chains and Stockpiling H.R. 8800 / S. 4784, National Defense Authorization for Fiscal Year 2027, Multiple Titles Defense Industrial Base Loans and Grants
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Natural Resources
$700,000
Spent on own lobbying
CitesS. 5653· this member:Sponsored
…oubt for Open Markets (FREEDOM) Act, All Titles H.R. 3872 / S. 3708, MERICA Act of 2025, All Titles S. 5587, National Critical Minerals Council Act, All Titles S. 5653, Bipartisan American Affordability and Jobs Act of 2026, Multiple Titles
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$700,000
Spent on own lobbying
CitesH.R. 5334· this member:Recorded votes on 4 roll calls
…ritical Energies (DOMINANCE) Act, All Titles S. 4392, Energy Security Pacts Act, All Titles S. 3772, Export-Import Bank Reauthorization Act of 2026, All Titles H.R. 5334, Lindsey O. Graham Sanctioning Russia and Iran Act of 2026, All Titles
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Transportation
$700,000
Spent on own lobbying
CitesS. 4949· this member:Sponsored
Rail Service Improvements for Mining Products Coal Ports H.R. 9497 / S. 4949, Water Resources Development Act of 2026, Multiple Titles
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FORD MOTOR COMPANY · lobbying firm or registrant: WILLIAMS AND JENSEN, PLLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$60,000
Paid to lobbying firm
CitesS. 4429· this member:Cosponsored
…the Trade Expansion Act of 1962, IEEPA (International Emergency Economic Powers Act of 1974), Section 301 of the Trade Act of 1974, or other trade authorities. S.4429 - Connected Vehicle Security Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
OHIO MUNICIPAL ELECTRIC ASSOCIATION · lobbying firm or registrant: OHIO MUNICIPAL ELECTRIC ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$70,000
Spent on own lobbying
CitesH.R. 9340· this member:Recorded vote on 1 roll call
…EAR) Act (Rep. Carter) S. _____ Senate Democratic Discussion Draft Transmission Bill (Padilla) H.R. 7977, Energy Bills Relief Act H.R. 2703, Advancing GETs Act H.R. 9340, Ratepayer Protection Act S. 3518, FLOWS Act H.R. 9337, Hydropower Licensing Affordability Act S. 5653, Bipartisan American Affordability and Jobs Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
